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Oligomeric stateBax is a cytosolic protein that responds to various apoptotic signals by binding to the outermitochondrial mem-
brane, resulting in membrane permeabilization, release of cytochrome c, and caspase-mediated cell death. Cur-
rently discussedmechanisms ofmembrane perforation include formation of hetero-oligomeric complexes of Bax
with other pro-apoptotic proteins such as Bak, or membrane insertion of multiple hydrophobic helices of Bax, or
formation of lipidic pores physically aided by mitochondrial membrane-inserted proteins. There is compelling
evidence provided by our and other groups indicating that the C-terminal “helix 9” of Bax mediates membrane
binding and pore formation, yet the mechanism of pore forming capability of Bax C-terminus remains unclear.
Here we show that a 20-amino acid peptide corresponding to Bax C-terminus (VTIFVAGVLTASLTIWKKMG)
and two mutants where the two lysines are replaced with glutamate or leucine have potent membrane pore
forming activities in zwitterionic and anionic phospholipidmembranes. Analysis of the kinetics of calcein release
from lipid vesicles allows determination of rate constants of pore formation, peptide–peptide afﬁnities within
the membrane, the oligomeric state of transmembrane pores, and the importance of the lysine residues. These
data provide insight into the molecular details of membrane pore formation by a Bax-derived peptide and
open new opportunities for design of peptide-based cytotoxic agents.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cellular homeostasis is regulated by cell renewal and apoptosis. Vari-
ous apoptotic stimuli result in recruitment of B cell lymphoma 2 (BCL-2)
family proteins to mitochondria, outer mitochondrial membrane perme-
abilization, release of cytochrome c, followed by caspase-mediated cell
death [1–4]. Formation of mitochondrial membrane pores is a critical
step, considered a point of no return in terms of cell life or death [2,3,5].
The existing evidence suggests that pro-apoptotic Bax, truncated Bid,
and Bak proteins form hetero-oligomeric structures in mammalian cells
upon activation that are directly involved in mitochondrial membrane
permeabilization [6–12]. The process is mediated by Ca2+ ions andwild-type Bax protein: Ac-
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l rights reserved.probably involves intermolecular disulﬁde bridging as Ca2+ and truncat-
ed Bid promoted Bax binding to isolated mitochondria, oligomerization,
and cytochrome c release, while dithiothreitol inhibited the effect [13].
However, even in the absence of Ca2+ and truncated Bid, Bax was
able to bind to mitochondria and form homo-oligomers with aggre-
gation numbers of 2 to 5 and higher [13]. Consistent with this,
recombinantly expressed and puriﬁed Bax was shown to form oligo-
meric structures in phospholipid membranes and cause leakage of
8-amino-naphthalene-1,3,6-trisulfonic acid (Mr≈384) from lipid vesi-
cles in the absence of any accessory factors [14]. These data indicate
that Bax indeed possesses an intrinsic propensity and capability of
membrane pore formation.
Structural similarity between certain BCL-2 family proteins, including
Bax, and bacterial toxins such as colicin and diphtheria toxin that form
endosome membrane pores at acidic pH [1,15,16] has prompted studies
on membrane pore formation by Bax and its pH dependence [17–21].
Functional studies involving point and deletion mutagenesis, as well as
the NMR structure of Bax, suggested that the hydrophobic C-terminal
α-helix 9 of Bax, and possibly helices 5 and 6, insert into the mito-
chondrial membrane upon apoptosis thus promoting pore formation
[1,10,22–27]. Bax with deleted C-terminus (BaxΔC) was incapable of mi-
tochondrial membrane binding and permeabilization [22–24], yet this
truncated version of Bax was used in many studies because the removal
of the “hydrophobic tail” rendered the protein water soluble and eased
its handling [17–21]. BaxΔC19 (i.e. Bax lacking C-terminal 19 residues)
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conductivity around pH 4.0 [18]. This echoes with results obtained
on BaxΔC20, which caused maximal release of carboxyﬂuorescein
(Mr≈326) from phospholipid vesicles at acidic pH of ~4.0, but is in con-
ﬂict with formation of cation-selective channels that were suppressed at
acidic pH [17]. Strong potency of BaxΔC19 to release carboxyﬂuorescein,
cytochrome c (Mr≈11,749), and large dextran molecules (Mr≥6000)
from lipid vesicles was demonstrated [20]. These latter data implied
that BaxΔC19 was able to form tetrameric pores in lipid membranes
with a diameter of 22 Å to 30 Å [16,20]. Membrane pore formation by
BaxΔC accords with its ability to release cytochrome c from isolatedmito-
chondria [19], but is not consistent with data indicating inability of BaxΔC
to localize to mitochondria and promote apoptosis [22–24] or to release
carboxyﬂuorescein from lipid vesicles [21]; the latter studies indicated
that the C-terminal stretch of Baxwas necessary for its in vivomembrane
permeabilization function. Yet another study demonstrated that BaxΔC20
could formonly small pores in lipid vesicles, and addition of truncatedBid
resulted in release of ﬂuorescein-conjugated dextrans ofMr~70,000 [25].
Furthermore, oligomeric full-length Bax (i.e. Bax solubilized in
octylglucoside) made pores in isolated mitochondrial membranes
or in lipid vesicles that could transfer cytochrome c and dextranmol-
ecules as large asMr ~2×106 [7,26], but untreated (monomeric) Bax
was unable to form pores large enough to transport cytochrome
c even when aided by truncated Bid [21].
In full-length Bax, the C-terminal helix 9 is located in a hydrophobic
groove [27]. This location is stabilized byH-bonding between Ser184 and
Asp98 and disruption of this H-bonding is thought to allow disengage-
ment of the C-terminus and insertion into themitochondrialmembrane
during apoptosis [1,23]. Logically, the isolated C-terminal peptide
would insert into lipid membranes and cause membrane leakage. A
synthetic peptide corresponding to Bax C-terminal 21 residues was in-
deed shown to bind to phospholipid vesicles and release vesicle-
entrapped carboxyﬂuorescein [28,29]. Moreover, our recent efforts to
develop peptide-based cytotoxic agents identiﬁed that the C-terminal
20-residue peptide of Bax, when delivered via polymeric nanoparticles,
is capable of efﬁciently killing breast and colon cancer cells, accompa-
nied with mitochondrial membrane hyperpolarization and plasma
membrane rupture [30]. Intratumoral or intravenous injections of the
nanoparticle-encapsulated peptide resulted in signiﬁcant tumor regres-
sion in mice within 4–9 days, and mutations of the two lysines to neu-
tral or acidic residues strongly altered the cytotoxic properties of theFig. 1. Calcein is self-quenched at high concentrations, and peptides do not cause vesicle rup
bandwidth were 490 nm and 2 nm, and emission wavelength and bandwidth were 515 nm
sities were generated by three independent experiments. B: Progression of calcein ﬂuoresc
total lipid concentration) loaded with 10 mM calcein. Gray lines at the lower part of the gra
measured following peptide addition, with periodicity of 20 s per spectrum. C: Light scatteri
ing addition of 10% buffer (inverted triangles), 0.6 mM DPC (closed triangles), 1.667 μM (ope
Triton X-100 (rhombs). The peptide has been initially solubilized in 6.0 mM DPC at a 10-fold
tions. Temperature was 37 °C, and all samples were in 20 mM Na,K-phosphate, 150 mM Npeptide. Despite the evidence for the strong potency of Bax C-terminal
peptide to kill cells through a mechanism involving perturbations of
the mitochondrial membrane, the molecular details of membrane
pore formation by the peptide, such as the kinetics of pore formation
and the oligomeric state of the pore, remain unclear.
The aim of this study is to analyze the membrane pore formation
mechanism by Bax C-terminal 20-residue peptide. The wild-type pep-
tide, as well as two mutants where the two lysines are replaced either
with glutamates (charge reversal) or leucines (charge neutralization),
form relatively large pores in zwitterionic and anionicmembranes. Con-
sistent with the cytotoxic effect of the peptide on cancer cells (see
above), the most efﬁcient pores are formed by the wild-type peptide
in anionic membranes. The kinetics of calcein (Mr≈623) release at var-
ious concentrations of the three peptides allowed identiﬁcation of the
second-order rate constants of pore formation within the membrane,
the afﬁnity constants of pore forming peptide units, and the oligomeric
pore structure. Nucleation of the pore is shown to be relatively slow and
involve 2–3 peptidemolecules, followed by a faster process of assembly
of the pore that includes up to eight peptidemolecules. It is clearly real-
ized that in vitro data on the behavior of the isolated peptide may not
directly reﬂect the mechanism of the full length Bax protein. However,
our efforts to analyze peptide-mediated cell death and the molecular
basis of formation of large membrane pores may facilitate design of
peptide-based cytolytic agents to eliminate detrimental cells such as
bacteria, fungi, or cancer cells.
2. Materials and methods
2.1. Materials
The lipids, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG),
and dodecylphosphocholine (DPC) were purchased from Avanti Polar
Lipids, Inc. (Alabaster, AL). Bax C-terminal peptide, named BaxC-KK
(Ac-VTIFVAGVLTASLTIWKKMG-NH2), and the two mutants where ly-
sines at positions 17 and 18were replacedwith glutamic acid or leucine
residues (BaxC-EE and BaxC-LL, respectively) were purchased from
Biopeptide Co., Inc. (San Diego, CA) and were >98% pure as document-
ed by HPLC and mass-spectrometry. The N- and C-termini of the pep-
tides were acetylated and amidated, respectively, to eliminate the
electrostatic effects of the terminal charges on the peptide behavior.ture. A: Concentration dependence of calcein ﬂuorescence. Excitation wavelength and
and 10 nm, respectively. Average values and standard deviations of ﬂuorescence inten-
ence spectra upon addition of 1.667 μM BaxC-KK peptide to POPC vesicles (at 0.5 mM
ph show the spectra before peptide addition, and the black lines correspond to spectra
ng at right angle from 10 mM calcein-loaded POPC vesicles (closed circles), and follow-
n triangles), 5.0 μM (squares), and 15.0 μM (open circles) of BaxC-KK peptide, or 0.05%
concentration so dilution into the vesicle suspension yielded the indicated concentra-
aCl, and 0.8 mM EGTA, pH 7.2.
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(Piscataway, NJ) and SM-2 Bio-beads were from Bio-Rad Laboratories
(Hercules, CA). Calcein disodium salt and other chemicals were of ana-
lytical grade and of the highest purity and were purchased from
Sigma-Aldrich (St. Louis, MO). Polycarbonate ﬁlters for extruded lipid
vesicle preparationwere purchased fromAvestin, Inc. (Ottawa, Ontario,
Canada).2.2. Calcein release assay
Large unilamellar vesicles (LUVs) were prepared by extrusion of
the lipid suspension through 200 nm pore-size polycarbonate ﬁlters,
as described [31], using 100% POPC or 70% POPC+30% POPG, at a
total lipid concentration of 10 mM in an aqueous buffer containing
20 mM Na,K-phosphate, 150 mM NaCl, 0.8 mM EGTA, pH 7.2, and
10 mM calcein disodium salt. Calcein at 10 mM has been shown to
yield little ﬂuorescence because of self-quenching [32]. Vesicles
were separated from calcein in the external medium by passing the
sample through a Sephadex G-50-packed desalting column (10 in.
by 0.7 in.) equilibrated with the same buffer without calcein. The
ﬂow rate was set at 1.0 mL/min using a peristaltic pump and
0.15 mL calcein-loaded vesicle fractions were collected. The lipid con-
centration was evaluated by measuring the right angle static light
scattering of the lipid vesicle suspension at 550 nm and comparingFig. 2. Peptides cause efﬁcient calcein release from vesicles. Kinetics of peptide-induced calc
at a 7:3 molar ratio (B, D, F). The peptides BaxC-KK (A, B), BaxC-EE (C, D) and BaxC-LL (E,
(triangles), 5.0 μM (squares), or 15.0 μM (circles). Inverted triangles and rhombs in panels
0.6 mM and 0.05%, respectively. Temperature, buffer, and other experimental conditions wwith a calibration curve. The ﬁnal lipid concentration was adjusted
to 0.5 mM by adding plane (calcein-free) buffer. The kinetics of
calcein release from LUVs was studied by measuring consecutive ﬂuo-
rescence spectra between 500 and 560 nm with 20 s periodicity, at
37 °C, on a J-810 spectroﬂuoropolarimeter (Jasco, Inc., Tokyo, Japan)
equipped with a PFD-425S Peltier temperature controller. The excita-
tion was at 490 nm, and the excitation and emission bandwidths
were 2 nm and 10 nm, respectively. Before addition of the peptide,
little ﬂuorescence was recorded because of self-quenching of calcein
at 10 mM. At 5 min into the measurements, a 1/10th volume of the
peptide solubilized in 6.0 mM DPC in a buffer of 20 mM Na,K-
phosphate, 150 mM NaCl, 0.8 mM EGTA, pH 7.2, was added to
calcein-loaded vesicles, followed by dispersion of DPC below its cmc
(~1.5 mM), transfer of the peptide into the vesicle membranes, and
calcein release, which was detected by measurements of consecutive
ﬂuorescence spectra for 25 more minutes. Membrane pore formation
capabilities were studied for the three peptides, i.e., the wild-type
peptide BaxC-KK and the two mutant peptides BaxC-EE and BaxC-
LL. Three concentrations of each of the three peptides were used,
i.e., 1.667 μM, 5.0 μM, and 15.0 μM. In positive control experiments,
0.05% Triton X-100 was added to the vesicles, resulting in complete
rupture of the vesicles. In negative control experiments, plane DPC
micelles or blank buffer was added. The buffer resulted in no increase
in ﬂuorescence, and the effect of DPC without the peptide was b5%
of that generated by the peptides. Before and after ﬂuorescenceein release from phospholipid vesicles composed of 100% POPC (A, C, E) or POPC/POPG
F) were added to 10 mM calcein-loaded vesicles at 300 s at concentrations 1.667 μM
A and B indicate the effects of plane DPC and Triton X-100 at ﬁnal concentrations of
ere as in Fig. 1.
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sured at 550 nm to determine if vesicle integrity was affected by
the peptides, DPC, or Triton X-100.3. Results and discussion
3.1. Membrane permeabilization by peptides
The C-terminal helix 9 of Bax is in a hydrophobic groove of the
protein, with the side chains of the two lysines oriented outward
(Fig. S1A of Supplementary data). Hydropathy analysis of Bax se-
quence using MPEx [33] indicated that the C-terminal helix 9 had a
substantial hydropathy index and hence a strong propensity to form
a transmembrane conformation that might mediate membrane pore
formation (Fig. S1B).
Membrane permeabilization by the peptides was studied by mon-
itoring peptide-induced calcein release from lipid vesicles. Calcein
ﬂuorescence is self-quenched at concentrations higher than ~1 mM
[32,34–36]. This results in a bell-shaped curve of the concentration-
dependence of calcein ﬂuorescence, as shown in Fig. 1A. If lipid vesicles
are loaded with calcein at a relatively high concentration, then mem-
brane permeabilization can be detected by calcein release into the
large external compartment, resulting in calcein dilution, dequenching,
and increase in ﬂuorescence intensity.We used lipid vesicles 200 nm in
diameter at 0.5 mM total lipid concentration loaded with 10 mM
calcein. Using 4.0 nm for POPC or POPC/POPG membrane thickness
[37] and 0.68 nm2 for cross-sectional area per lipid [38], one can evalu-
ate a 0.31% fraction of vesicle-entrapped volume. Upon total disruption
of the vesicles, calcein concentration in the external volume will in-
crease from zero to ~0.03 mM, which corresponds to an increase in
ﬂuorescence intensity to 1.0–1.1 relative units, as judged from data of
Fig. 1A. Fig. 1B shows the representative ﬂuorescence spectra indicating
a rapid increase in calcein ﬂuorescence intensity upon addition of
1.667 μM of BaxC-KK to calcein-loaded vesicles. To ensure that calcein
release from the vesicles was due to membrane pore formation rather
than vesicle rupture, vesicle integrity was estimated by right angle
light scattering on a J-810 spectroﬂuoropolarimeter. When incident
light was used at 550 nm, slightly red-shifted light scattering from
vesicles was detected (Fig. 1C). Addition of 1/10th volume of buffer
resulted in a ~10% decrease in intensity of scattered light due to dilutionFig. 3. Pore formation by BaxC-KK peptide is a biphasic process. Time-dependence of vesicle c
by the peptides (see Eq. (3)). Panels A and B correspond to vesicles composed of pure POP
respond to BaxC-KK peptide concentrations of 1.667 μM, 5.0 μM, and 15.0 μM, respectively
interactions in the membrane, leading to pore formation.of the vesicle suspension. Addition of 1/10th volume of plane DPC (at
ﬁnal DPC concentration of 0.6 mM) or any of the three peptides solubi-
lized in DPC at ﬁnal peptide concentration of 1.667 μM to15 μMdid not
result in any additional decrease in light scattering, indicating that nei-
ther the peptides nor DPC below its cmc of 1.5 mM caused vesicle dis-
ruption. However, the possibility that pore formation by the peptides
is accompanied with membrane destabilization cannot be ruled out.
Triton X-100 caused strong reduction of light scattering. The residual
scattering was due to mixed Triton X-100-lipid micelles, indicating
complete degradation of the vesicles by Triton X-100.
To exclude the possibility that the observed effect of calcein release
could result from a nonspeciﬁc action of peptide–DPC complex on the
vesicles, additional experiments have been conducted where two dif-
ferent peptides have been solubilized in DPC micelles and added to
calcein-loaded vesicles. An amphipathic peptide corresponding to
N-terminus of human group IB phospholipase A2, named IB, and a hy-
drophobic peptide corresponding to the C-terminal “transmembrane”
domain of Bcl-xL, named XL, were tested. As shown in Fig. S2A, B, addi-
tion of empty DPCmicelles to calcein-loaded POPC or POPC/POPG (7:3)
vesicles caused a mall reduction of calcein ﬂuorescence, reﬂecting sam-
ple dilution and hence indicating practically zero effect of DPC. Addition
of DPC micelles containing the IB peptide to POPC vesicles did not elicit
any appreciable calcein release (Fig. S2C), and caused a slight effect of
calcein release in case of anionic POPC/POPG vesicles (Fig. S2D). Addi-
tion of DPC micelles containing the XL peptide exerted a moderate ef-
fect on POPC vesicles but caused a strong time-dependent calcein
release from POPC/POPG vesicles (Fig. S2E, F). These data clearly indi-
cate that a) DPC itself does not cause membrane permeabilization, b)
the IB peptide, which is known to bind to phospholipid membranes pe-
ripherally [31] exerts little permeabilizing effect on membranes, and c)
the Bcl-xL peptide, which is known to insert in artiﬁcial and biological
membranes and causemembrane leakage [39] efﬁciently permeabilizes
the membranes. Hence, calcein release directly correlates with the in-
trinsic membranotropic properties of the peptides.3.2. Kinetics and mechanism of pore formation
Addition of the peptides to calcein-loaded vesicles resulted in a grad-
ual increase in calcein ﬂuorescence, apparently induced by membrane
permeabilization by the peptides and calcein release (Fig. 2). While theontent release is presented using a second-order reaction formalism for pore formation
C and POPC/POPG at a 7:3 molar ratio, respectively. Triangles, squares, and circles cor-
. The slope of the graphs indicates the second-order rate constant of peptide–peptide
Table 1
Kinetic parameters of calcein release from vesicles composed of 100% POPC (PC) or 70% POPC+30% POPG (PC/PG) derived from ﬁtting the data with a double-exponential equation:
Ft=Feq−a1exp(−k1t)−a2exp(−k2t), where Ft is calcein ﬂuorescence intensity at time t, Feq is Ft at t→∞, k1 and k2 are the rate constants. Cp is the peptide concentration in μM.
Cp Feq a1 a2 k1 (s−1) k2 (s−1)
PC PC/PG PC PC/PG PC PC/PG PC PC/PG PC PC/PG
BaxC-KK
1.667 0.5622 0.5969 0.2974 0.1917 0.2633 0.3724 0.002939 0.001936 0.086286 0.038464
5.0 0.6224 0.6312 0.1722 0.2236 0.4508 0.3949 0.002589 0.002632 0.105304 0.050731
15.0 0.6920 0.6726 0.1555 0.1618 0.5283 0.5078 0.0035407 0.005551 0.074997 0.115064
BaxC-EE
1.667 0.3811 0.2555 0.1652 0.1175 0.2008 0.1387 0.001164 0.000817 0.000401 0.002029
5.0 0.5912 0.6078 0.4165 0.4592 0.1784 0.1529 0.001362 0.001256 0.015592 0.008628
15.0 0.7075 0.7020 0.2238 0.2382 0.4733 0.4596 0.003443 0.003539 0.025874 0.015385
BaxC-LL
1.667 0.2076 0.3264 0.1244 0.2412 0.07143 0.0784 0.000629 0.001130 0.004593 0.007391
5.0 0.2781 0.5085 0.2002 0.3918 0.07003 0.1085 0.001035 0.000573 0.017925 0.011937
15.0 0.3969 0.6134 0.1933 0.2302 0.2013 0.3390 0.001136 0.001239 0.010174 0.000376
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and the concentration of the peptide and the lipid composition of vesicle
membranes, all kinetic curves demonstrated a double-exponential char-
acter, as shown in Fig. S3. All traces of time-dependence of calcein ﬂuo-
rescence could be ﬁtted with Ft=Feq−a1exp(−k1t)−a2exp(−k2t),
where Ft is the calcein ﬂuorescence intensity at time t, offset by subtrac-
tion of the ﬂuorescence before peptide addition, Feq is the extrapolatedFig. 4. Pore formation by BaxC-EE and BaxC-LL peptides tends to be a monophasic process. D
formalism for pore formation by peptides BaxC-EE (A, B) and BaxC-LL (C, D) in membranes o
circles correspond to peptide concentrations of 1.667 μM, 5.0 μM, and 15.0 μM, respectivel
interactions.level ofﬂuorescence at t→∞, a1 and a2 are the fractions of the twokinetic
components, and k1 and k2 are the respective rate constants. The time
constants of the fast and slow components were within the range of
0.2–1.5 min and 3–30 min, respectively, depending on the peptide
type and concentration and the membrane charge (Table 1).
Upon membrane binding of the peptides and pore formation, the
observed calcein ﬂuorescence increases and reaches an equilibriumescription of time-dependence of vesicle content release using a second-order reaction
f 100% POPC (A, C) or 70% POPC+30% POPG (B, D) membranes. Triangles, squares, and
y. The slope of the graphs indicates the second-order rate constant of peptide–peptide
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concentration of free peptide at time t, [P]t, can be expressed through
the total peptide concentration, [P]0, and ﬂuorescence intensity at
time t, Ft, as follows:
P½ t ¼ P½ 0 1−
Ft
Feq
 !
: ð1Þ
Given the hydrophobic nature of the peptides and their poor
water solubility, it is reasonable to assume that nearly all of the pep-
tide ends up in vesicle membranes upon dispersion of DPC. We use a
model of pore formation where peptide molecules associate with
each other in a stepwise fashion to form an oligomeric assembly
[34,40–42]. If the pore is composed of n≥2 peptide molecules, then
addition of each monomer to the assembly can be considered a
second-order process that is described as follows [43]:
1
P½ t
− 1
P½ 0
¼ kat ð2Þ
where ka is the second-order rate constant in units M−1 s−1. Combi-
nation of Eqs. (1) and (2) yields:
Feq
P½ 0 Feq−Ft
  ¼ 1
P½ 0
þ kat: ð3Þ
Eq. (3) indicates that the second-order rate constant of pore for-
mation, ka, can be determined as the slope of the time dependence
of the term at the left-hand side of Eq. (3). Values of Feq/{[P]0(Feq−
Ft)} were calculated using Ft and Feq from the experimental kinetic
curves shown in Fig. 2 and Fig. S3 and were plotted vs. time. (Values
of Feq are tabulated in Table 1.) Data of Fig. 3 indicate an initial linear
time dependence of Feq/{[P]0(Feq−Ft)}, characteristic of a bimolecular
reaction, followed by a second segment of linear dependence with a
higher slope at t≥10 min after addition of the wild-type BaxC-KK
peptide to calcein-loaded vesicles (for POPC/POPG vesicles and
15 μM peptide, the second linear segments start earlier). The data
points corresponding to the second linear segment are considerably
scattered because with increasing time Ft approaches Feq and the
values of Feq/{[P]0(Feq−Ft)} become progressively unstable as the de-
nominator approaches zero.
Generally, a bimolecular process where reactants A and B combine
in a complex AB, which then either dissociates to A and B or leads toTable 2
The fraction of maximum possible vesicle content leakage (Frel), second-order rate constants
brane pore formation by the peptides. Parameters ka1 and K1 were derived from the data for
ka2 and K2 were derived from data corresponding to later times (between 10 and 20 min).
Cp Frel ka1 (M−1 s−1) ka2 (M−1 s−1)
PC PC/PG PC PC/PG PC
BaxC-KK
1.667 0.755 0.843 8966 7190 41,800
5.0 0.836 0.892 4459 4608 34,090
15.0 0.929 0.950 4871 7318 21,973
BaxC-EE
1.667 0.513 0.332 552 1276 1092
5.0 0.796 0.789 710 594 1672
15.0 0.952 0.912 1852 2389 6892
BaxC-LL
1.667 0.317 0.407 1208 1526 –
5.0 0.425 0.634 598 243 –
15.0 0.606 0.765 373 70 –the formation of the ﬁnal product P, can be described as shown in
Scheme 1 [43]:
Aþ B⇌kakdAB→
kp
P: Scheme1
Here, ka and kd are the forward and reverse rate constants of com-
plex formation, and kp is the rate constant of product formation. The
effective (observed) rate constant of product formation is
keff ¼
kakp
kp þ kd
: ð4Þ
Two cases can be considered. First, product formation is much
faster than complex dissociation (kp≫kd). This leads to:
keff≈ka: ð5Þ
Second, complex dissociation is much faster than product forma-
tion (kp≪kd). This leads to:
keff≈
kakp
kd
¼ Kkp: ð6Þ
Here, K=ka/kd is the peptide–peptide association (afﬁnity) con-
stant in units M−1.
Two linear segments of the graphs shown in Fig. 3 indicate that at
least two processes are involved in membrane pore formation. The
ﬁrst question to be answered is whether any of the two processes
are related to diffusion of the peptide molecules in the membrane.
The second-order rate constant of a diffusion-controlled bimolecular
process is [43]: kdiff=4πRDNA, where R is the distance of closest ap-
proach between the two reactants, D is the sum of diffusion coefﬁ-
cients of the two reactants, and NA is Avogadro's number. The
diffusion coefﬁcients of lipid or peptide molecules in ﬂuid lipid mem-
branes are in the range 1×10−8 to 1×10−7 cm2/s−1 [44]. The dis-
tance of interaction of two peptides in α-helical or β-strand
conformations is ~1.0 or ~0.5 nm, respectively [45,46]. With these
considerations, we estimate kdiff=8×106 to 1.5×108 M−1 s−1. The
rate constants ka1 and ka2 shown in Table 2 are at least 103-fold small-
er than the estimated value of kdiff, indicating that the pore formation
is much slower than a simple diffusion-controlled process. This in
turn implies that in most cases peptides can diffuse away from each
other before the complex is formed. Thus, the rate constant of peptide(ka1 and ka2), and peptide–peptide afﬁnity constants (K1 and K2) characterizing mem-
initial time period (up to 10 min) following addition of peptides to the vesicles, while
Cp is the peptide concentration in μM.
K1 (M−1) K2 (M−1)
PC/PG PC PC/PG PC PC/PG
21,407 3.05×106 3.71×106 1.42×107 1.11×107
19,538 1.72×106 1.75×106 1.31×107 7.42×106
26,868 1.37×106 7.71×105 6.21×106 4.84×106
2267 4.74×105 1.56×106 9.38×105 2.77×106
1010 5.21×105 4.73×105 1.23×106 8.04×105
8156 5.38×105 6.75×105 2.00×106 2.30×106
2748 1.92×106 1.35×106 – 2.43×106
– 5.77×105 4.24×105 – –
– 3.28×105 1.87×105 – –
Fig. 5. BaxC-KK pores contain 3–4 molecules in the nucleation complex and up to 8 molecules in the mature pore. Dependence of the fraction of vesicle content leakage relative the
maximum leakage (Frel) on the concentration of BaxC-KK peptide. Experimental data at three peptide concentrations are presented along with curves simulated according to a re-
versible aggregation model (Eq. (9)), using various numbers of peptide molecules involved in pore formation, as indicated at the left hand side of the curves. Panels A and C cor-
respond to POPC vesicles, and panels B and D to POPC/POPG (7:3) vesicles. Curves shown in panels A and B are simulated using the rate constant, ka, for earlier times following
peptide addition, i.e. corresponding to the ﬁrst linear segments of traces shown in Fig. 3. Curves shown in panels C and D are simulated using the rate constant, ka, for later
times following peptide addition, i.e. corresponding to the second linear segments of traces shown in Fig. 3. All curves are simulated using the slow components of double expo-
nential rate constants summarized in Table 1.
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according to Eq. (6), keff=Kkp. Here, keff is the observed second-
order rate constant, i.e. those summarized in Table 2 as ka1 and ka2,
K is the peptide–peptide association constant, and kp is the rate con-
stant of peptide complex formation. Since vesicle content leakage re-
sults from peptide complex formation in the membrane, one of the
double-exponential rate constants that describe the observed kinetics
of calcein release can be used for kp. Peptide–peptide binding con-
stants evaluated using both ka1 and ka2, which describe the experi-
mental data at earlier and later time periods following peptide
addition, in combination with the rate constant corresponding to
the slow component of double-exponential time course are presented
in Table 2 as K1 and K2. Binding constants have also been evaluated
using the rate constants corresponding to the fast component of
double-exponential time course, but these values were far beyond
the experimental observations and therefore have been discarded
(see below).
Analysis of the kinetic data on vesicle content leakage induced by
BaxC-KK indicates two distinct processes with rate constants of
5000–9000 M−1 s−1 and 20,000–40,000 M−1 s−1 (Table 2). The
slower process likely reﬂects the nucleation of the pore complex,
which is the rate-limiting step of pore formation and is characterized
with peptide–peptide afﬁnity constants of K1=(0.8–3.7)×106 M−1.
The second process is interpreted in terms of formation of the ﬁnalpore structure, which proceeds at a 4-fold higher speed and results
in peptide–peptide association with afﬁnity constants of K2=(0.5–
1.4)×107 M−1.
Similar analysis of data for BaxC-EE and BaxC-LL mutant peptides
indicated distinct features of membrane pore formation by these mol-
ecules. BaxC-EE showed a strong biphasic feature of the time course
of pore formation only for the highest peptide concentration of
15 μM (Fig. 4A, B). The peptide–peptide afﬁnity constants corre-
sponding to the initial and later phases of pore formation were ap-
proximately an order of magnitude lower than those of the wild-
type BaxC-KK peptide (Table 2). BaxC-LL peptide displayed a linear
time course of pore formation, except for POPC/POPG membranes at
the lowest concentration of 1.667 μM (Fig. 4C, D). The peptide–pep-
tide afﬁnity constants characterizing these monophasic processes of
complex formation were (0.2–2.0)×106 M−1 (Table 2), i.e. compara-
ble to those for the wild type peptide at initial times. However, the
larger slope of the second phase of time dependence of pore forma-
tion by BaxC-LL in POPC/POPGmembranes (Fig. 4D, triangles) yielded
a larger afﬁnity constant of 2.4×106 M−1. Thus, pore formation by
the mutant peptides tends to be a monophasic process, especially in
case of the most hydrophobic peptide BaxC-LL. The peptide–peptide
afﬁnity constants involved in the initial pore nucleation are in
the range (0.1–3.7)×106 M−1 and those involved in the formation
of the more stable pore structure are (0.8–14)×106 M−1. These
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to −13 kcal/mol, respectively. Considering that the strength of pep-
tide hydrogen bonding is close to −1.5 kcal/mol [47,48], these pep-
tide–peptide binding energies are equivalent to up to 8 hydrogen
bonds and should be viewed as strong enough to sustain an oligomer-
ic pore structure.3.3. The oligomeric state of the pore
The number of peptide monomers per pore can be estimated using
a formalism of reversible aggregation [34,40,41]. This model is appli-
cable to general cases when the sample contains j=1 to S different
types of vesicles, such as vesicles of different size categories, and
each vesicle of type j contains up to Nj peptide molecules. If the num-
ber of peptides per pore is n, then leakage will be observed when the
number of peptides per vesicle i is in the range n≤ i≤Nj. The fraction
of leakage reached at t→∞ (Feq, see above) relative to the maximum
possible leakage (Fmax) caused by vesicle rupture by Triton X-100, is
given as:
Frel ¼
Feq
Fmax
¼ qn−1 n−nqþ qð Þ
h i
Σ
Nj
i¼n
Σ
S
j¼1
Ai;jf j ð7ÞFig. 6. BaxC-EE pores contain up to 6–8 peptide molecules. Dependence of the fraction of
BaxC-EE peptide. Experimental data at three peptide concentrations are presented along wit
numbers of peptide molecules involved in pore formation, as indicated at the left hand side
POPG (7:3) vesicles. Curves shown in panels A and B are simulated using the rate constant,
ments of traces shown in Fig. 4A, B. Curves shown in panels C and D are simulated using th
second linear segments of traces shown in Fig. 4A, B. All curves are simulated using the slowhere
q ¼ 1
α þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
α2−1
p ð7aÞ
α ¼ 1þ 1
4K P½ 0
: ð7bÞ
In Eq. (7), Ai,j is the normalized fraction of vesicles of size j that con-
tain i bound peptides, and fj is the fraction of encapsulated volume of
vesicles of type j normalized relative to the total encapsulated volume.
Considering that the vesicles used in this work have been obtained by
extrusion through ﬁlters of deﬁned pore size (200 nm), only one type
of vesicles can be considered, i.e., S=1. Furthermore, it is reasonable to
assume that all vesicles contain similar numbers of peptides, i.e. the av-
erage number of peptidemolecules per vesicle. Under our experimental
conditions (total lipid concentration of 0.5 mM and peptide concentra-
tions of 1.667 μM, 5.0 μM, and 15.0 μM), this number varied between
1,180 and 10,650, which is much larger than any conceivable number
of peptide molecules per pore. With these considerations, we arrive at
XS
j¼1
f j ¼ 1 and
XNj
i¼n
Ai;j ¼ 1: ð8Þvesicle content leakage relative the maximum leakage (Frel) on the concentration of
h curves simulated according to a reversible aggregation model (Eq. (9)), using various
of the curves. Panels A and C correspond to POPC vesicles, and panels B and D to POPC/
ka, for earlier times following peptide addition, i.e. corresponding to the ﬁrst linear seg-
e rate constant, ka, for later times following peptide addition, i.e. corresponding to the
w components of double exponential rate constants summarized in Table 1.
Fig. 7. BaxC-LL pores contain up to 5–7 peptide molecules. Dependence of the fraction of vesicle content leakage relative the maximum leakage (Frel) on the concentration of
BaxC-LL peptide. Experimental data at three peptide concentrations are presented along with curves simulated according to a reversible aggregation model (Eq. (9)), using various
numbers of peptide molecules involved in pore formation, as indicated at the left hand side of the curves. Panels A and B correspond to POPC and POPC/POPG (7:3) vesicles, respec-
tively. Curves are simulated using the rate constant, ka, deduced from the linear traces shown in Fig. 4C, D (for POPC/POPG membranes at 1.667 μM peptide concentration, the value
of ka corresponding to the initial time domain is used.) All curves are simulated using the slow components of double exponential rate constants summarized in Table 1.
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Frel ¼ qn−1 n−nqþ qð Þ: ð9Þ
If experiments of vesicle content release are performed at various
peptide concentrations, then the experimental values of Frel can be
determined at each concentration and compared with those calculat-
ed through Eq. (9) using different values for n. Values of n at which
the calculated and measured values of Frel merge will indicate the
number of peptide molecules per pore. It should be noted that this
procedure of determination of n is more accurate than a model con-
sidering an irreversible aggregation, in which overestimated values
of n are obtained [42].
Experimental values of relative leakage, Frel=Feq/Fmax, were deter-
mined for each peptide concentration for both POPC and POPC/POPG
membranes and plotted vs. peptide concentration. Values of Frel were
then calculated through Eq. (9) using various numbers of peptide
molecules per pore (parameter n in Eq. (9)) and plotted vs. peptide
concentration. The number of peptide molecules in the pore structure
was found as the parameter n at which an agreement was reached be-
tween the theoretical and experimental data. Calculations of Frel in-
volved the peptide–peptide afﬁnity constant K=keff/kp, where keff
and kp are the second-order rate constant in units M−1 s−1 derived
from the graphs of Figs. 3 and 4 and the observed rate constant of ves-
icle leakage in units s−1 given by the double-exponential curves
shown in Fig. S3. Since we have two values for keff and two for kp,
total four plots have been constructed for each peptide-membrane
pair. As shown in Fig. S4, the data could be described by the curves
simulated using the slow double-exponential component, while the
theoretical curves obtained using the fast component of the double-
exponential time course (dashed lines) were far off the range of ex-
perimental data. Therefore, the mechanism of pore formation was an-
alyzed using the slower double-exponential rate constants, which
apparently reﬂect the kinetics of pore formation.
Fig. 5 indicates that when values of ka1 are used, which characterize
the pore formation process at earlier times (5–10 min), the experimen-
tal data for BaxC-KK agree with n≈3–4 for POPC membranes (Fig. 5A)
and n≈2–3 for POPC/POPG membranes (Fig. 5B). When values of ka2
are used, which characterize further progression of pore formation pro-
cess, the data are consistent with n≈8 for POPC membranes (Fig. 5C)
and n≈5 for POPC/POPGmembranes (Fig. 5D). Thus, the overall picture
of membrane pore formation by the wild-type BaxC-KK peptide is that
the peptide molecules form an initial nucleation complex, whichinvolves 2–4 molecules and is characterized with afﬁnity constants of
(0.8–3.7)×106 M−1, followed by a more efﬁcient process (higher 2nd
order rate constant) of the assembly of theﬁnal pore structure involving
up to 8 peptide molecules associated with afﬁnity constants of (0.5–
1.4)×107 M−1.
Evaluation of the oligomeric state of the pores formed by BaxC-EE
was consistent with 2–3 peptide molecules in the nucleation complex
that increased with time to a larger number (3–4 for POPC and 4–7
for POPC/POPG membranes) (Fig. 6). The number of BaxC-LL peptide
molecules in the pore complex was estimated to be 5–7 for POPC
membranes and 3–5 for POPC–POPG membranes (Fig. 7). However,
data corresponding to the second phase of pore formation in POPC/
POPG membranes by 1.667 μM BaxC-LL peptide (Fig. 4D, triangles)
indicate n=6–7 molecules in the pore complex.
Althoughmembrane pore formation has been demonstrated for Bax
helices 5, 6, and 9, [28,29,49,50], molecular details such as the oligomer-
ic state of the pore, the kinetic and peptide–peptide afﬁnity parameters
have not been reported. Our data indicate up to eight peptidemolecules
assemble within the membrane, stabilized by afﬁnity constants of 106–
107 M−1, and form membrane pores that efﬁciently transport calcein
molecules. Peptide-induced release of calcein from lipid vesicles indi-
cates the pores are quite large, at least 13 Å in diameter, as the hydrody-
namic radius of calcein is 6.4 Å [51]. Numbers of pore-forming peptide
units in the pore between 3 and 10 have been reported [35,41,
42,52–56].While our data are consistent with amaximum of eight pep-
tide molecules in the pore structure, formation of pores with a lower
oligomeric state cannot be ruled out. The oligomeric state of the pore
may depend on factors like the membrane surface charge and the pep-
tide sequence, as shown, for example, for melittin [35] and the GALA
peptide [57]. The efﬁciency of pore formation by the wild-type
BaxC-KK peptide, as judged from the second-order rate constants and
afﬁnity constants summarized in Table 2, is by an order of magnitude
greater as compared to the BaxC-EE and BaxC-LL mutants. However,
no clear correlation was detected between pore formation and the
membrane surface charge. Also, the kinetic and afﬁnity constant for
the cationic BaxC-KK pore formation in anionic membranes exceeded
those of the anionic BaxC-EE peptide less than 10-fold (Table 2). The
fact that thewild-type andmutant Bax peptides,which signiﬁcantly dif-
fer in their charge, form pores in both zwitterionic and anionic mem-
branes with only slight differences indicates that the peptides use the
“barrel-stave” rather than the “carpet”mechanism, i.e., the hydrophobic
peptide–membrane interactions dominate over electrostatic interac-
tions [58].
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membrane pore formation by Bax C-terminal peptide. As conﬁrmed
by our tryptophan ﬂuorescence quenching data (not shown), the
peptide signiﬁcantly inserts into the membrane hydrophobic core,
consistent with the barrel-stave mechanism. The second-order rate
constants of pore nucleation and assembly of the mature pore indi-
cate that pore formation is slower, and hence more complex, than a
simple diffusion-controlled process. Interactions between the peptide
monomers within the membrane are evidently followed by formation
of a speciﬁc structure, leading to the ﬁnal pore architecture that is
supported by high-afﬁnity (−10 to −13 kcal/mol) peptide–peptide
interactions. Our attenuated total reﬂection Fourier transform infra-
red studies indicate that the peptide molecules include α-helical
and β-strand secondary structures, both of which are tilted relative
to the membrane normal (unpublished data). Infrared data were
obtained on stacked lipid–peptide ﬁlms on a germanium plate
under conditions where the ﬁlm thickness signiﬁcantly exceeded
the evanescent wave decay length, so only the membrane-inserted
peptide molecules could contribute to the spectra. Altogether, the
C-terminal 20-residue peptide of Bax emerges as a potent cytotoxic
agent that is able to form transmembrane pores containing up to
eight monomers and at least 13 Å in diameter. Further analysis of
the structural basis of membrane pore formation will allow develop-
ment of novel cytotoxic peptides.4. Conclusions
Bax is known to bind to the mitochondrial membrane and directly
mediate cytochrome c release, supposedly by a pore forming mecha-
nism. The C-terminal peptide of Bax alone was shown to permeabilize
lipid membranes. Moreover, our recent data indicated that the pep-
tide, when delivered via polymer-based nanoparticles, has a strong
cytotoxic potency against breast and colon cancer cells in mice [30].
Thus, the peptide corresponding to Bax C-terminus emerges as an at-
tractive molecular tool for development of cytotoxic therapeutics,
which will require a better understanding of its membrane pore
formation mechanism. This work clearly demonstrates that the C-
terminal 20-residue stretch of Bax has the capability of forming rela-
tively large membrane pores with a radius of at least 13 Å. Replace-
ment of the two lysine residues close to the C-terminus with
anionic glutamate or nonpolar leucine residues reduces the pore
forming activity of the peptide, consistent with the lethal effects of
the peptides on cancer cells. Data on calcein release kinetics at vari-
ous peptide concentrations allow determination of the second-order
rate constants of pore formation, the intermolecular afﬁnities of pep-
tide molecules within the pore, and the oligomeric state of the pore.
In general, the pore formation is a two-stage process, nucleation
and assembly of the ﬁnal pore structure that includes up to eight pep-
tide molecules and is stabilized by intermolecular interaction
energies of −10 to −13 kcal/mol. The pore forming activities of the
peptides can be exploited for therapeutic purposes. For example,
the membrane pore forming activity of Bax helix 5 has been used to
cause caspase-dependent cell death and tumor regression in mice
[5]. Thus, the importance of our ﬁndings is two-fold. First, the potent
membrane pore forming activity of Bax C-terminus accentuates its
potential role in membrane permeabilization by Bax. Second, based
on our data, cytotoxic peptide-based molecular tools can be devel-
oped for cell membrane perforation and killing of unwanted cells
such as bacteria, fungi, or cancer cells.Acknowledgements
Financial support from the National Institutes of Health grant
GM083324 is gratefully acknowledged.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2012.08.006.References
[1] A. Antignani, R.J. Youle, How do Bax and Bak lead to permeabilization of the outer
mitochondrial membrane? Curr. Opin. Cell Biol. 18 (2006) 685–689.
[2] B. Leber, J. Lin, D.W. Andrews, Embedded together: the life and death consequences
of interaction of the Bcl-2 family with membranes, Apoptosis 12 (2007) 897–911.
[3] R.J. Youle, A. Strasser, The BCL-2 protein family: opposing activities that mediate
cell death, Nat. Rev. Mol. Cell Biol. 9 (2008) 47–59.
[4] S.W. Tait, D.R. Green, Mitochondria and cell death: outer membrane perme-
abilization and beyond, Nat. Rev. Mol. Cell Biol. 11 (2010) 621–632.
[5] J.G. Valero, L. Sancey, J. Kucharczak, Y. Guillemin, D. Gimenez, J. Prudent, G. Gillet,
J. Salgado, J.L. Coll, A. Aouacheria, Bax-derived membrane-active peptides act as
potent and direct inducers of apoptosis in cancer cells, J. Cell Sci. 124 (2011)
556–564.
[6] B. Antonsson, S. Montessuit, B. Sanchez, J.C. Martinou, Bax is present as a high
molecular weight oligomer/complex in the mitochondrial membrane of apopto-
tic cells, J. Biol. Chem. 276 (2001) 11615–11623.
[7] X. Roucou, S. Montessuit, B. Antonsson, J.C. Martinou, Bax oligomerization in mi-
tochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochon-
drial protein, Biochem. J. 368 (2002) 915–921.
[8] J.D. Robertson, B. Zhivotovsky, V. Gogvadze, S. Orrenius, Outer mitochondrial mem-
brane permeabilization: an open-and-shut case? Cell Death Differ. 10 (2003)
485–487.
[9] L. Zhou, D.C. Chang, Dynamics and structure of the Bax–Bak complex responsible
for releasing mitochondrial proteins during apoptosis, J. Cell Sci. 121 (2008)
2186–2196.
[10] A.J. Garcia-Sáez, G. Fuertes, J. Suckale, J. Salgado, Permeabilization of the outer mi-
tochondrial membrane by Bcl-2 proteins, Adv. Exp. Med. Biol. 677 (2010) 91–105.
[11] L. Ghibelli, M. Diederich, Multistep and multitask Bax activation, Mitochondrion
10 (2010) 604–613.
[12] D. Westphal, G. Dewson, P.E. Czabotar, R.M. Kluck, Molecular biology of Bax and
Bak activation and action, Biochim. Biophys. Acta 1813 (2011) 521–531.
[13] T. Brustovetsky, T. Li, Y. Yang, J.T. Zhang, B. Antonsson, N. Brustovetsky, BAX
insertion, oligomerization, and outer membrane permeabilization in brain
mitochondria: role of permeability transition and SH-redox regulation, Biochim.
Biophys. Acta 1797 (2010) 1795–1806.
[14] R.F. Epand, J.C. Martinou, S. Montessuit, R.M. Epand, C.M. Yip, Direct evidence for
membrane pore formation by the apoptotic protein Bax, Biochem. Biophys. Res.
Commun. 298 (2002) 744–749.
[15] Y. Lazebnik, Why do regulators of apoptosis look like bacterial toxins? Curr. Biol.
11 (2001) R767–R768.
[16] P.H. Schlesinger, M. Saito, The Bax pore in liposomes, Biophys. Cell Death Differ.
13 (2006) 1403–1408.
[17] B. Antonsson, F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi,
A. Bernard, J.J. Mermod, G.Mazzei, K.Maundrell, F. Gambale, R. Sadoul, J.C.Martinou,
Inhibition of Bax channel-forming activity by Bcl-2, Science 277 (1997) 370–372.
[18] P.H. Schlesinger, A. Gross, X.M. Yin, K. Yamamoto, M. Saito, G. Waksman, S.J.
Korsmeyer, Comparison of the ion channel characteristics of proapoptotic BAX
and antiapoptotic BCL-2, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11357–11362.
[19] J.M. Jurgensmeier, Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen, J.C. Reed, Bax di-
rectly induces release of cytochrome c from isolated mitochondria, Proc. Natl.
Acad. Sci. U. S. A. 95 (1998) 4997–5002.
[20] M. Saito, S.J. Korsmeyer, P.H. Schlesinger, BAX-dependent transport of cyto-
chrome c reconstituted in pure liposomes, Nat. Cell Biol. 2 (2000) 553–555.
[21] X. Roucou, T. Rostovtseva, S. Montessuit, J.C. Martinou, B. Antonsson, Bid induces
cytochrome c-impermeable Bax channels in liposomes, Biochem. J. 363 (2002)
547–552.
[22] K.G. Wolter, Y.T. Hsu, C.L. Smith, A. Nechushtan, X.G. Xi, R.J. Youle, Movement of
Bax from the cytosol to mitochondria during apoptosis, J. Cell Biol. 139 (1997)
1281–1292.
[23] A. Nechushtan, C.L. Smith, Y.T. Hsu, R.J. Youle, Conformation of the Bax C-terminus
regulates subcellular location and cell death, EMBO J. 18 (1999) 2330–2341.
[24] R.J. Boohaker, G. Zhang, A.L. Carlson, K.N. Nemec, A.R. Khaled, BAX supports the
mitochondrial network, promoting bioenergetics in nonapoptotic cells, Am. J.
Physiol. Cell Physiol. 300 (2011) C1466–C1478.
[25] O. Terrones, B. Antonsson, H. Yamaguchi, H.G. Wang, J. Liu, R.M. Lee, A. Herrmann,
G. Basanez, Lipidic pore formation by the concerted action of proapoptotic BAX
and tBID, J. Biol. Chem. 279 (2004) 30081–30091.
[26] T. Kuwana, M.R. Mackey, G. Perkins, M.H. Ellisman, M. Latterich, R. Schneiter, D.R.
Green, D.D. Newmeyer, Bid, Bax, and lipids cooperate to form supramolecular
openings in the outer mitochondrial membrane, Cell 111 (2002) 331–342.
[27] M. Suzuki, R.J. Youle, N. Tjandra, Structure of Bax: coregulation of dimer forma-
tion and intracellular localization, Cell 103 (2000) 645–654.
[28] M. del Mar Martinez-Senac, S. Corbalan-Garcia, J.C. Gomez-Fernandez, Conforma-
tion of the C-terminal domain of the pro-apoptotic protein Bax and mutants and
its interaction with membranes, Biochemistry 40 (2001) 9983–9992.
[29] A. Torrecillas, M.M. Martinez-Senac, A. Ausili, S. Corbalan-Garcia, J.C. Gomez-
Fernandez, Interaction of the C-terminal domain of Bcl-2 family proteins with
model membranes, Biochim. Biophys. Acta 1768 (2007) 2931–2939.
742 P. Garg et al. / Biochimica et Biophysica Acta 1828 (2013) 732–742[30] R.J. Boohaker, G. Zhang, M.W. Lee, K.N. Nemec, S. Santra, J.M. Perez, A.R. Khaled,
Rational development of a cytotoxic peptide to trigger cell death, Mol. Pharm. 9
(2012) 2080–2093.
[31] S. Qin, A.H. Pande, K.N. Nemec, S.A. Tatulian, The N-terminal alpha-helix of pan-
creatic phospholipase A2 determines productive-mode orientation of the enzyme
at the membrane surface, J. Mol. Biol. 344 (2004) 71–89.
[32] F.N. Fu, B.R. Singh, Calcein permeability of liposomes mediated by type A botuli-
num neurotoxin and its light and heavy chains, J. Protein Chem. 18 (1999)
701–707.
[33] C. Snider, S. Jayasinghe, K. Hristova, S.H. White, MPEx: a tool for exploring mem-
brane proteins, Protein Sci. 18 (2009) 2624–2628.
[34] D. Rapaport, R. Peled, S. Nir, Y. Shai, Reversible surface aggregation in pore forma-
tion by pardaxin, Biophys. J. 70 (1996) 2502–2512.
[35] S.C. Park, J.Y. Kim, S.O. Shin, C.Y. Jeong, M.H. Kim, S.Y. Shin, G.W. Cheong, Y. Park,
K.S. Hahm, Investigation of toroidal pore and oligomerization by melittin using
transmission electron microscopy, Biochem. Biophys. Res. Commun. 343 (2006)
222–228.
[36] G. Klocek, T. Schulthess, Y. Shai, J. Seelig, Thermodynamics ofmelittin binding to lipid
bilayers. Aggregation and pore formation, Biochemistry 48 (2009) 2586–2596.
[37] M. Vogel, C. Munster, W. Fenzl, T. Salditt, Thermal unbinding of highly oriented
phospholipid membranes, Phys. Rev. Lett. 84 (2000) 390–393.
[38] J. Seelig, S. Nebel, P. Ganz, C. Bruns, Electrostatic and nonpolar peptide–
membrane interactions. Lipid binding and functional properties of somatostatin
analogues of charge z=+1 to z=+3, Biochemistry 32 (1993) 9714–9721.
[39] A.J. García-Sáez, I. Mingarro, E. Pérez-Payá, J. Salgado, Membrane-insertion frag-
ments of Bcl-xL, Bax, and Bid, Biochemistry 43 (2004) 10930–10943.
[40] S. Nir, J.L. Nieva, Interactions of peptides with liposomes: pore formation and
fusion, Prog. Lipid Res. 39 (2000) 181–206.
[41] J.L. Nieva, A. Agirre, S. Nir, L. Carrasco, Mechanisms of membrane perme-
abilization by picornavirus 2B viroporin, FEBS Lett. 552 (2003) 68–73.
[42] R.A. Parente, S. Nir, F.C. Szoka Jr., Mechanism of leakage of phospholipid vesicle
contents induced by the peptide GALA, Biochemistry 29 (1990) 8720–8728.
[43] P.W. Atkins, Physical Chemistry, W.H. Freeman and Company, New York, 1999.
[44] P.F.F. Almeida, W.L.C. Vaz, Lateral diffusion in membranes, in: R. Lipowsky, E.
Sackmann (Eds.), Structure and Dynamics of Membranes: From Cells to Vesicles,
Elsevier, Amsterdam, 1995, pp. 305–357.
[45] S. Lee, G.S. Chirikjian, Interhelical angle and distance preferences in globular pro-
teins, Biophys. J. 86 (2004) 1105–1117.[46] S. Arnott, S.D. Dover, A. Elliott, Structure of beta-poly-L-alanine: reﬁned atomic
co-ordinates for an anti-parallel beta-pleated sheet, J. Mol. Biol. 30 (1967)
201–208.
[47] A.R. Fersht, J.P. Shi, J. Knill-Jones, D.M. Lowe, A.J. Wilkinson, D.M. Blow, P. Brick, P.
Carter, M.M. Waye, G. Winter, Hydrogen bonding and biological speciﬁcity
analysed by protein engineering, Nature 314 (1985) 235–238.
[48] D.H. Williams, M.S. Searle, J.P. Mackay, U. Gerhard, R.A. Maplestone, Toward an
estimation of binding constants in aqueous solution: studies of associations of
vancomycin group antibiotics, Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1172–1178.
[49] A.J. Garcia-Saez, M. Coraiola, M. Dalla Serra, I. Mingarro, G. Menestrina, J. Salgado,
Peptides derived from apoptotic Bax and Bid reproduce the poration activity of
the parent full-length proteins, Biophys. J. 88 (2005) 3976–3990.
[50] A.J. Garcia-Saez, M. Coraiola, M.D. Serra, I. Mingarro, P. Muller, J. Salgado, Peptides
corresponding to helices 5 and 6 of Bax can independently form large lipid pores,
FEBS J. 273 (2006) 971–981.
[51] J. Zimmerberg, R. Blumenthal, D.P. Sarkar, M. Curran, S.J. Morris, Restricted move-
ment of lipid and aqueous dyes through pores formed by inﬂuenza hemaggluti-
nin during cell fusion, J. Cell Biol. 127 (1994) 1885–1894.
[52] F. Nicol, S. Nir, F.C. Szoka Jr., Effect of cholesterol and charge on pore formation in
bilayer vesicles by a pH-sensitive peptide, Biophys. J. 71 (1996) 3288–3301.
[53] Z. Chang, Y. Luo, Y. Zhang, G. Wei, Interactions of Aβ25-35 β-barrel-like oligomers
with anionic lipid bilayer and resulting membrane leakage: an all-atom molecu-
lar dynamics study, J. Phys. Chem. B 115 (2011) 1165–1174.
[54] G. Agner, Y.A. Kaulin, P.A. Gurnev, Z. Szabo, L.V. Schagina, J.Y. Takemoto, K. Blasko,
Membrane-permeabilizing activities of cyclic lipodepsipeptides, syringopeptin 22A
and syringomycin E from Pseudomonas syringae pv. syringae in human red blood
cells and in bilayer lipid membranes, Bioelectrochemistry 52 (2000) 161–167.
[55] N. Saint, L. Marri, D. Marchini, G. Molle, The antibacterial peptide ceratotoxin A dis-
plays alamethicin-like behavior in lipid bilayers, Peptides 24 (2003) 1779–1784.
[56] S. Wen, M. Majerowicz, A. Waring, F. Bringezu, Dicynthaurin (ala) monomer
interaction with phospholipid bilayers studied by ﬂuorescence leakage and iso-
thermal titration calorimetry, J. Phys. Chem. B 111 (2007) 6280–6287.
[57] F. Nicol, S. Nir, F.C. Szoka Jr., Orientation of the pore-forming peptide GALA in
POPC vesicles determined by a BODIPY-avidin/biotin binding assay, Biophys. J.
76 (1999) 2121–2141.
[58] M.L. Mangoni, Y. Shai, Short native antimicrobial peptides and engineered ultra-
short lipopeptides: similarities and differences in cell speciﬁcities and modes of
action, Cell. Mol. Life Sci. 68 (2011) 2267–2280.
